Cancer Dx, a first-of-its-kind test to provide early detection of lymphoma in dogs launched in January <Link> and is now available for veterinary practices in the U.S. and Canada. Developed by IDEXX Cancer Dx is an accessible blood test with 99 percent specificity and 79 percent sensitivity that can be added to panels for sick pets. It can also be integrated into annual wellness screenings to select preventive care panels for as low as $15.
Source: IDEXX, March 31, 2025. Link.
Leave a Reply